Impact of perfluorooctanesulfonate and perfluorooctanoic acid on human peripheral leukocytes

Toxicology in Vitro

Volumn 25, Issue 4, 2011, Pages 960-968

  Brieger, Anne ^a   Bienefeld, Nicole ^a   Hasan, Rafah ^a   Goerlich, Roland ^a   Haase, Hajo ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Immunotoxicity; Leukocytes; Lymphocytes; Perfluorinated compound; Perfluorooctanesulfonate; Perfluorooctanoic acid

Indexed keywords

CALCITRIOL; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PERFLUOROOCTANESULFONIC ACID; PERFLUOROOCTANOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BLOOD LEVEL; CELL DIFFERENTIATION; CELL STIMULATION; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKOCYTE; LEUKOCYTE FUNCTION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; PILOT STUDY; PROTEIN SYNTHESIS INHIBITION;

ADULT; ALKANESULFONIC ACIDS; FEMALE; FLUOROCARBONS; HL-60 CELLS; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; OCTANOIC ACIDS; TUMOR NECROSIS FACTOR-ALPHA;

RODENTIA;

EID: 79955481876     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2011.03.005     Document Type: Article

References (40)

1. Bernsmann T., Fürst P. Determination of perfluorinated compounds in human milk. Organohalogen Compounds 2008, 70:718-721.
2. Biegel L.B., Hurtt M.E., Frame S.R., O'Connor J.C., Cook J.C. Mechanism of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicological Science 2001, 60:44-55.
3. Butenhoff J., Costa G., Elcombe C., Farrar D., Hansen K., Iwai H., Jung R., Kennedy G., Lieder P., Olsen G.W., Thomford P. Toxicity of ammonium perfluorooctanoate in male cynomolgus monkeys after oral dosing for 6months. Toxicological Science 2002, 69:244-257.
4. DeWitt J.C., Copeland C.B., Strynar M.J., Luebke R.W. Perfluorooctanoic acid-induced immunomodulation in adult C57BL/6J or C57BL/6N female mice. Environmental Health Perspectives 2008, 116:644-650.
5. DeWitt J.C., Shnyra A., Badr M.Z., Loveless S.E., Hoban D., Frame S.R., Cunard R., Anderson S.E., Meade B.J., Peden-Adams M.M., Luebke R.W., Luster M. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of Peroxisome Proliferator-Activated Receptor Alpha. Critical Reviews in Toxicology 2009, 39:76-94.
6. Dong G.H., Zhang Y.H., Zheng L., Liang Z.F., Jin Y.H., He Q.C. Subchronic effects of perfluorooctanesulfonate exposure on inflammation in adult male C57BL/6 mice. Environmental Toxicology 2010, doi:10.1002/tox.20642.
7. Dong G.H., Zhang Y.H., Zheng L., Liu W., Jin Y.H., He Q.C. Chronic effects of perfluorooctanesulfonate exposure on immunitoxicity in adult male C57BL/6 mice. Archives of Toxicology 2009, 83:805-815.
8. Dubben S., Hönscheid A., Winkler K., Rink L., Haase H. Cellular zinc homeostasis is a regulator in monocyte differentiation of HL-60 cells by 1 alpha, 25-dihydroxyvitamin D3. Journal of Leukocyte Biology 2010, 87:833-844.
9. Fromme H., Schlummer M., Möller A., Gruber L., Wolz G., Ungewiss J., Böhmer S., Dekant W., Meyer R., Lieble B., Twardella D. Exposure of an adult population to perfluorinated substances using duplicate diet portions and biomonitoring data. Environmental Science and Technology 2007, 41:7928-7933.
10. Guruge K.S., Hikono H., Shimada N., Murakami K., Hasegawa J., Yeung L.W.Y., Yamanaka N., Yamashita N. Effect of perfluorooctane sulfonate (PFOS) on influenza A virus-induced mortality in female B6C3F1 mice. The Journal of Toxicological Science 2009, 34:687-691.
11. Kannan K., Corsolini S., Falandysz J., Fillmann G., Kumar K.S., Loganathan B.G., Mohd M.A., Olivero J., van Wouwe N., Yang J.H., Aldous K.M. Perfluorooctanesulfonate and related fluorochemicals in human blood from several countries. Environmental Science and Technology 2004, 38:4489-4495.
12. Keil D.E., Mehlmann T., Butterworth L., Peden-Adams M.M. Gestational exposure to perfluorooctane sulfonate suppresses immune function in B6C3F1 mice. Toxicological Science 2008, 103:77-85.
13. Kennedy G.L., Butenhoff J.L., Olsen G.W., O'Connor J.C., Seacat A.M., Perkins R.G., Biegel L.B., Murphy S.R., Farrar D.G. The toxicology of perfluorooctanoate. Critical Reviews in Toxicology 2004, 34:351-384.
14. Kovarova J., Svobodova Z. Perfluorinated compounds: occurrence and risk profile. Neuro Endocrinology Letters 2008, 29:599-608.
15. Lau C., Anitole K., Hodes C., Lai D., Pfahles-Hutchens A., Seed J. Perfluoroalkyl acids: a review of monitoring and toxicological findings. Toxicological Science 2007, 99:366-394.
16. Lefebvre D.E., Curran I., Armstrong C., Coady L., Parenteau M., Liston V., Barker M., Aziz S., Rutherford K., Bellon-Gallon P., Shenton J., Mehta R., Bondy G. Immunomodulatory effects of dietary potassium perfluorooctane sulfonate (PFOS) exposure in adult sprague-dawley rats. Journal of Toxicology and Environmental Health, Part A 2008, 71:1516-1525.
17. Loveless S.E., Finlay C., Everds N.E., Frame S.R., Gillies P.J., O'Connor J.C., Powley C.R., Kennedy G.L. Comparative responses of rats and mice exposed to linear/branched, linear, or branched ammonium perfluorooctanoate (APFO). Toxicology 2006, 220:203-217.
18. Loveless S.E., Hoban D., Sykes G., Frame S.R., Everds N.E. Evaluation of the immune system in rats and mice administered linear ammonium perfluorooctanoate. Toxicological Science 2008, 105:86-96.
19. Maloney E.K., Waxman D.J. Trans-activation of PPARα and PPARγ by structurally diverse environmental chemicals. Toxicology and Applied Pharmacology 1999, 161:209-218.
20. Midasch O., Schettgen T., Angerer J. Pilot study on the perfluorooctanesulfonate and perfluorooctanoate exposure of the German general population. International Journal of Hygiene and Environmental Health 2006, 209:489-496.
21. Mollenhauer M.A.M., Bradshaw S.G., Fair P.A., McGuinn W.D., Peden-Adams M.M. Effects of perfluorooctane sulfonate (PFOS) exposure on markers of inflammation in female B6C3F1 mice. Journal of Environmental Science and Health Part A 2011, 46:97-108.
22. Nakata A., Katsuma T., Iwasaki Y., Ito R., Saito K., Izumi S., Makino T., Kishi R., Nakazawa H. Measurement of perfluorinated compounds in human milk and house dust. Organohalogen Compounds 2008, 69:2844-2846.
23. Nelson D.L., Frazier D.E., Ericson J.E., Tarr M.J., Mathes L.E. The effects of perfluorodecanoic acid (PFDA) on humoral, cellular, and innate immunity in fischer 344 rats. Immunopharmacology and Immunotoxicology 1992, 14:925-938.
24. Olsen G.W., Burris J.M., Burlew M.M., Mandel J.H. Epidemiologic assessment of worker serum perfluorooctanesulfonate (PFOS) and perfluorooctanoate (pfoa) concentrations and medical surveillance examinations. Journal of Occupational and Environmental Medicine 2003, 45:260-270.
25. Olsen G.W., Burris J.M., Ehresman D.J., Froehlich J.W., Seacat A.M., Butenhoff J.L., Zobel L.R. Half-life of serum elimination of perfluorooctanesulfonate, perfluorohexanesulfonate, and perfluorooctanoate in retired fluorochemical production workers. Environmental Health Perspectives 2007, 115:1298-1305.
26. Olsen G.W., Burris J.M., Mandel J.H., Zobel L.R. Serum perfluorooctane sulfonate and hepatic and lipid clinical chemistry tests in fluorochemical production employees. Journal of Occupational and Environmental Medicine 1999, 41:799-806.
27. Peden-Adams M.M., EuDaly J.G., Dabra S., EuDaly A., Heesemann L., Smythe J., Keil D.E. Suppression of humoral immunity following exposure to the perfluorinated insecticide sulfuramid. Journal of Toxicology and Environmental Health, Part A 2007, 70:1130-1141.
28. Peden-Adams M.M., Keller J.M., EuDaly J.G., Berger J., Gilkeson G.S., Keil D.E. Suppression of humoral immunity in mice following exposure to perfluorooctane sulfonate. Toxicological Science 2008, 104:144-154.
29. Perkins R.G., Butenhoff J.L., Kennedy G.L., Palazzolo M.J. 13-week dietary toxicity study of ammonium perfluorooctanoate (APFO) in male rats. Drug and Chemical Toxicology 2004, 27:361-378.
30. Prevedouros K., Cousins I.T., Buck R.C., Korzeniowski S.H. Sources, fate and transport of perfluorocarboxylates. Environmental Science and Technology 2006, 4:32-40.
31. Qazi M.R., Xia Z., Bogdanska J., Chang S.C., Ehresman D.J., Butenhoff J.L., Nelson B.D., DePierre J.W., Abedi-Valugerdi M. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha). Toxicology 2009, 260:68-76.
32. Qazi M.R., Bogdanska J., Butenhoff J.L., Nelson B.D., DePierre J.W., Abedi-Valugerdi M. High-dose, short-term exposure of mice to perfluorooctanesulfonate (PFOS) or perfluorooctanoate (PFOA) affects the number of circulating neutrophils differently, but enhances the inflammatory responses of macrophages to lipopolysaccharide (LPS) in a similar fashion. Toxicology 2009, 262:207-214.
33. Seacat A.M., Thomford P.J., Hansen K.J., Olsen G.W., Case M.T., Butenhoff J.L. Subchronic toxicity studies on perfluorooctanesulfonate potassium salt in cynomolgus monkeys. Toxicological Science 2002, 68:249-264.
34. Seacat A.M., Thomford P.J., Hansen K.J., Clemen L.A., Eldridge S.R., Elcombe C.R., Butenhoff J.L. Sub-chronic dietary toxicity of potassium perfluorooctanesulfonate in rats. Toxicology 2003, 183:117-131.
35. Shipley J.M., Hurst C.H., Tanaka S.S., DeRoos F.L., Butenhoff J.L., Seacat A.M., Waxman D.J. Trans-activation of PPARα and induction of PPARα target genes by perfluorooctane-based chemicals. Toxicological Science 2004, 80:151-160.
36. Son H.-Y., Lee S., Tak E.-N., Cho H.-S., Shin H.-I., Kim S.-H., Yang J.H. Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice. Environmental Toxicology 2009, 24:580-588.
37. Yang Q., Xie Y., DePierre J.W. Effects of peroxisome proliferators on the thymus and spleen of mice. Clinical and Experimental Immunology 2000, 122:219-226.
38. Yang Q., Abedi-Valugerdi M., Xie Y., Zhao X.-Y., Möller G., Nelson B.D., DePierre J.W. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. International Immunopharmacology 2002, 2:389-397.
39. Yang Q., Xie Y., Eriksson A.M., Nelson B.D., DePierre J.W. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. Biochemical Pharmacology 2001, 62:1133-1140.
40. Zheng L., Dong G.H., Jin Y.H., He Q.C. Immunotoxic changes associated with a 7-day oral exposure to perfluorooctanesulfonate (PFOS) in adult male C57BL/6 mice. Archives of Toxicology 2009, 83:679-689.